Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Diagnosis, treatment and monitoring of diabetic eye control].
Radda S, Bolz M, Egger S, Gasser-Steiner V, Kralinger M, Mennel S, Scholda C, Stolba U, Wedrich A, Krepler K. Radda S, et al. Among authors: kralinger m. Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S97-102. doi: 10.1007/s00508-016-0983-z. Wien Klin Wochenschr. 2016. PMID: 27052229 Review. German.
[Diagnosis, treatment and monitoring of diabetic eye disease (Update 2019)].
Radda S, Bolz M, Egger S, Gasser-Steiner V, Kralinger M, Mennel S, Scholda C, Stolba U, Wedrich A; die Netzhautkommission der Österreichischen Ophthalmologischen Gesellschaft. Radda S, et al. Among authors: kralinger m. Wien Klin Wochenschr. 2019 May;131(Suppl 1):164-168. doi: 10.1007/s00508-019-1445-1. Wien Klin Wochenschr. 2019. PMID: 30980159 Review. German.
Safety and feasibility of a novel intravitreal tamponade using a silicone oil/acetyl-salicylic acid suspension for proliferative vitreoretinopathy: first results of the Austrian Clinical Multicenter Study.
Kralinger MT, Stolba U, Velikay M, Egger S, Binder S, Wedrich A, Haas A, Parel JM, Kieselbach GF. Kralinger MT, et al. Graefes Arch Clin Exp Ophthalmol. 2010 Aug;248(8):1193-8. doi: 10.1007/s00417-010-1389-7. Epub 2010 Apr 28. Graefes Arch Clin Exp Ophthalmol. 2010. PMID: 20424852 Clinical Trial.
[Degenerative maculopathy (in younger patients)].
Haas G, Treiblmayr B, Kralinger M, Bechrakis NE. Haas G, et al. Among authors: kralinger m. Klin Monbl Augenheilkd. 2014 Dec;231(12):1239-55. doi: 10.1055/s-0033-1358018. Epub 2014 Nov 13. Klin Monbl Augenheilkd. 2014. PMID: 25393434 German. No abstract available.
[Patient Mobility and Journey Distance as Risk Factors for Severe Visual Impairment: Real-Life Data Analysis of Treatment-naïve Patients with nAMD under Intravitreal Aflibercept Therapy].
Rauchegger T, Angermann R, Meusburger A, Schwab J, Haas G, Kralinger M, Zehetner C. Rauchegger T, et al. Among authors: kralinger m. Klin Monbl Augenheilkd. 2020 Jun;237(6):789-796. doi: 10.1055/a-1008-9357. Epub 2019 Nov 26. Klin Monbl Augenheilkd. 2020. PMID: 31770790 German.
Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema.
Zehetner C, Kirchmair R, Huber S, Kralinger MT, Kieselbach GF. Zehetner C, et al. Br J Ophthalmol. 2013 Apr;97(4):454-9. doi: 10.1136/bjophthalmol-2012-302451. Epub 2013 Feb 5. Br J Ophthalmol. 2013. PMID: 23385630 Clinical Trial.
51 results